Steven Cohen Genocea Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $25,763 - $3.56 Million	-2,576,385 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.96 - $1.35 $73,525 - $103,395	-76,589 Reduced 2.89%	2,576,385 $3.22 Million
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.33 $266,174 - $356,429	152,974 Added 6.12%	2,652,974 $5.09 Million
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $5.15 Million - $7.05 Million	2,500,000 New	2,500,000 $5.85 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.